Clorox Company (The)

Valuation Analysis

About the Company

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the Uni

Clorox Company (The) Stock at a Glance

Clorox Company (The) (CLX) is currently trading at $96.82 with a market capitalization of $11.7B. The trailing P/E ratio stands at 15.74x, with a forward P/E of 15.38x. The 52-week range spans from $84.70 to $132.03; the current price is 26.7% below the yearly high. Year-over-year revenue growth stands at +0.1%. The net profit margin stands at 11.18%.

💰 Dividend

Clorox Company (The) pays an annual dividend of $4.96 per share, representing a yield of 5.12%. The payout ratio stands at 80.33%. The elevated payout ratio reflects a mature dividend policy.

📊 Analyst Rating

17 analysts rate Clorox Company (The) (CLX) on consensus: Hold. The average price target is $105.29, implying +8.75% from the current price. Analyst price targets range from $83.00 to $163.00.

Clorox Company (The): The Investment Case in Detail

Clorox Company (The) (CLX) operates in the Consumer Defensive — specifically Household & Personal Products — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

The combination of a 43.85% gross margin and 17.01% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Return on equity of 546.1% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

The Bear Case

Revenue growth has slowed to just 0.1%, which is below nominal GDP — the business is no longer outgrowing the broader economy. The debt-to-equity ratio of 4876.09% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

The price is in a transition zone relative to the moving averages — no clear signal.

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (8.85%), higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Clorox Company (The)?

Compare top-rated brokers — low fees, trusted providers, fully regulated.